Masonic Cancer Center, University of Minnesota

What's Inside

Quick Links for:

Cancer Information Line
Ask about cancer, clinical trials, and how to make an appointment:
ccinfo@umn.edu
612-624-2620

Toll-free in IA, MN, ND, SD, WI: 1-888-CANCER MN
(1-888-226-2376)

A Comprehensive Cancer Center Designated by the National Cancer Institute

Print this page. Mail this link to a friend.

Cancer Center Seminar Series 2004-2005


DATE
TOPIC
SPEAKER
HOST
09/14/04
 Prostate cancer prevention:  Opportunities for nutrition and chemoprevention

 

Seminar co-sponsored by Department of Food Science and Nutrition

Steven K. Clinton, M.D., Ph.D.

Associate Professor

College of Medicine and Public Health

Co-leader of the Molecular Carcinogenesis and Chemoprevention Program

  Comprehensive Cancer Center

Ohio State University
Alice Shapiro
09/21/04

 The structural basis for tissue specificity:

The role of the microenvironment in breast cancer

Mina J. Bissell, Ph.D.

Distinguished Scientist

Lawrence Berkely National Laboratory

Berkeley, CA

Jim McCarthy
09/28/04
 Receptor tyrosine kinase dysregulation in canine spontaneous tumors: A model for human cancer
Cheryl London, DVM, PhD Assistant Professor Department of Surgical and Radiological Sciences College of Veterinary Medicine University of California - Davis
 Elizabeth McNiel
10/05/04
 The menage-a-trois between tumor cell, dendritic cell and T cell

 Drew Pardoll, MD, PhD

Professor

Johns Hopkins University

Sidney Kimmel Cancer Center

 Wei Chen
10/12/04
Ras oncogenesis

David A. Tuveson, M.D., Ph.D.

Assistant Professor

Department of Medicine & Cancer Biology

University of Pennsylvania

Abramson Family Cancer Research Institute

David Largaespada
10/19/04
Translational control of cancer
Vitaly A Polunovsky, Ph.D. Professor of Medicine University of Minnesota
 
10/26/04

  Variegated expression of class I MHC receptors on NK cells:

Some things are best left to chanc

Stephen K. Anderson, Ph.D.
Principal Investigator
Laboratory of Experimental Immunology
National Cancer Institute-Frederick
 
  Jeff Miller
11/02/04

ELECTION DAY

SEMINAR CANCELLED

 
 
11/09/04
  Identification of potential biomarkers for ovarian carcinoma by differential gene microarray analysis

Amy Skubitz, Ph.D.

Associate Professor

Department of Laboratory Medicine & Pathology

University of Minnesota

  
  
11/16/04

Head and Neck Carcinogenesis Program at the University of Minnesota

Nelson L. Rhodus, D.M.D, M.P.H. Professor and Director of Oral Medicine Academy of Distinguished Professors

Frank Ondrey, M.D., Ph.D.

Assistant Professor

Department of Otolaryngology University of Minnesota

 

11/23/04

SEMINAR CANCELLED

 

 

11/30/04

Wnt signaling regulation of LEF-1 expression in colon cancer

Marian L. Waterman, Ph.D.

Associate Professor

Department of Microbiology and Molecular Genetics

University of California-Irvine

Jennifer Westendorf

12/07/04
NO SEMINAR DUE TO ASH MEETING

 

 

12/14/04

Molecular regulation of c-Fos gene expression by CD28 costimulatory signals in CD4 T cells

Daniel Mueller, M.D.

Professor

Department of Medicine

Director of Rheumatic and Autoimmune Diseases

University of Minnesota

 

12/21/04
Exploiting NQO1, a tumor-selective and stress-inducible oxidoreductase, using ß-lapachone

 

David A. Boothman, Ph.D.

Professor of Radiation Oncology

Associate Director for Basic Research

Case Comprehensive Cancer Center

Case Western Reserve University

Chang Song

12/28/04
SEMINAR CANCELLED DUE TO HOLIDAYS

 

 

01/04/05

Immuno-gene therapy for thoracic malignancies: From bench to bedside and back to the bench

  Daniel Sterman, M.D.

Associate Professor of Medicine Director of Interventional Pulmonology Clinical Director, Thoracic Oncology Gene Therapy Program

University of Pennsylvania Medical Center

Robert Kratzke

01/11/05

Immunotherapy of malignant melanoma

Douglas Schwartzentruber, M.D.

Medical Director, Surgical Oncologist Center for Cancer Care at Goshen Health System Goshen, Indiana

Arkadiusz Dudek

01/18/05

Active cytosine deamination in carcinogenesis?

Reuben Harris, Ph.D.

Assistant Professor

Department of Biochemistry, Molecular Biology and Biophysics

University of Minnesota

 

 

01/25/05

Glycemic load, weight maintenance, insulin resistance, and colorectal c ancer

Andrew Flood, Ph.D. Assistant Professor Department of Epidemiology University of Minnesota

 

02/01/05

RANKL signaling and osteoclast differentiation

Kim Mansky, Ph.D.

Assistant Professor

Diagnostic Surgical Sciences

School of Dentistry

University of Minnesota

 

02/08/05

Initiating DNA Replication: how Mcm10 controls S phase progression

Anja-Katrin Bielinsky Assistant Professor Department of Biochemistry, Molecular Biology and Biophysics

University of Minnesota

 

02/15/05

Mammary Tumorigenesis in Transforming Growth Factor Alpha Transgenic Mice

Teresa Rose-Hellekant, Ph.D. Assistant Professor  Department of Physiology

University of Minnesota-Duluth              

 

02/22/05

Hepatitis C Infection after Childhood Cancer

Melissa M. Hudson, MD Department of Hematology-Oncology

Director, After Completion of Therapy Clinic

St. Jude Children's Research Hospital

Memphis, TN

Les Robison

03/01/05

CANCELLED

Notch signaling in leukemia: new insights

Jon C. Aster, M.D., Ph.D.

Associate Professor Department of Pathology Harvard Medical School Head of Research

Hematopathology Training Program

Brigham and Women's Hospital

Director

Hematopathology Core

Dana Farber/Harvard Comprehensive Cancer Center

Tucker LeBien

03/08/05

Molecular mechanism of mammalian DNA interstrand crosslink repair

Tadayoshi Bessho, Ph.D.

Assistant Professor

Eppley Institute   University of Nebraska Medical Center

Natalia Tretyakova

03/15/05

The bio-behavioral determinants of adolescent smoking progression

Janet Audrain-McGovern, Ph.D.

Department of Psychiatry

University of Pennsylvania

Katie Schmitz

03/22/05

Cholesterol as a mediator of cell signaling in prostate cancer

Michael R. Freeman, Ph.D. David E. Retik Director of Basic Urologic Research Children's Hospital Associate Professor of Surgery Harvard Medical School

Carol Lange

03/29/05

Gap junctions, the cell cycle and cancer

Paul Lampe, Ph.D. Associate Research Professor

University of Washington
School of Public Health and Community Medicine

Pathobiology Associate Member

Fred Hutchinson Cancer Research Center

Cancer Prevention Program

Lee Wattenberg

04/05/05

Studying death and promiscuity in a simplified model of oncogenic transformation

Yuri Lazebnik, Ph.D.

Professor

Cold Spring Harbor Laboratory

Ameeta Kelekar

04/12/05

Cross-talk between TGF-beta signaling and androgen axis in prostate cancer

Natasha Kyprianou, Ph.D. Professor of Surgery Division of Urology James F. Hardymon Chair of Urological Research Professor of Molecular and Cellular Biochemistry Markey Cancer Center University of Kentucky

Khalil Ahmed

04/19/05
NO SEMINAR DUE TO AACR ANNUAL MEETING

 

 

04/26/05

Targeting tumors with genetically enhanced T lymphocytes

Michel Sadelain, M.D., Ph.D.

Director

Gene Transfer and Somatic Cell Engineering Facility

Immunology Program

Memorial Sloan Kettering Cancer Center

Bruce Blazar

05/03/05

Chemically assisted screen identifies novel angiogenic mutations in the zebrafish

Joanne Chan, Ph.D. Assistant Professor of Surgery

Harvard Medical School Program in Vascular Biology Children's Hospital Karp Family Research Laboratories

Steve Ekker

05/10/05
Notch signaling at the interface of
lymphoid development and cancer

 

Warren Pear, M.D., Ph.D.

Associate Professor

Department of Pathology and Laboratory Medicine Institute for Medicine and Engineering Abramson Family Cancer Research Institute

University of Pennsylvania

Philadelphia, PA

Catherine Verfaillie

05/17/05
Brain cancer therapies - why everything has failed so far: Where the future lies

Maria G. Castro, Ph.D.

Professor of Medical and Molecular Pharmacology, UCLA Co-Director of

the Gene Therapeutics Research Institute

Cedars-Sinai Medical Center

David Largaespada/Andrew Freese

5/24/05
Tyrosine kinase inhibitors: Successes, limitations, future directions

Carlos L. Arteaga, M.D. Director, VICC Breast Cancer Program Professor of Medicine and Cancer Biology Vanderbilt University School of Medicine

Doug Yee